‹ All Posts
Chahat Aggrawal

13th Apr · SEBI-Registered Analyst

Piramal Pharma Gets VAI Status from US FDA

🧪

PPLPHARMA
has successfully completed a US FDA inspection at its Lexington facility, receiving a Voluntary Action Indicated (VAI) status, indicating satisfactory compliance with regulatory standards.

#FundamentalViews#WatchOutFor
421 likes·50 comments